MedTrace Logo

CLE for Differential Diagnosis of IBD

NCT02238665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2014-09-12

No results posted yet for this study

Summary

Differential diagnosis between Ulcerative Colitis (UC) and Crohn's disease (CD) is of pivotal importance for the management of Inflammatory Bowel Disease (IBD) as both entities involve specific therapeutic management strategies. Confocal Laser Endomicroscopy (CLE) allows on demand in vivo characterization of architectural and cellular details during endoscopy. Here, we assessed the efficacy of CLE to differentiate between UC and CD.

Conditions

  • Inflammatory Bowel Diseases

Interventions

DEVICE

Endomicroscopy

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Helmut Neumann, Professor · University Hospital Erlangen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2013-04-30
Completion
2014-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02238665 on ClinicalTrials.gov